Get the Stockscreener App
2.72
1.49%
0.04
Pre-market:
2.80
0.08
+2.94%
Alaunos Therapeutics Inc stock is traded at $2.72, with a volume of 15,877.
It is up +1.49% in the last 24 hours and up +12.86% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.68
Open:
$2.71
24h Volume:
15,877
Relative Volume:
0.03
Market Cap:
$6.00M
Revenue:
$6,000
Net Income/Loss:
$-3.99M
P/E Ratio:
-1.1038
EPS:
-2.4643
Net Cash Flow:
$-2.85M
1W Performance:
-3.55%
1M Performance:
+12.86%
6M Performance:
+11.02%
1Y Performance:
+32.68%
1-Day Range:
$2.652
$2.8183
1-Week Range:
$2.62
$2.8976
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.72 | 5.91M | 6,000 | -3.99M | -2.85M | -2.4643 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Can you recover from losses in Alaunos Therapeutics Inc.Trade Risk Report & Long-Term Safe Investment Plans - newser.com
Custom strategy builders for tracking Alaunos Therapeutics Inc.Weekly Profit Summary & Risk Managed Investment Strategies - newser.com
Market reaction to Alaunos Therapeutics Inc.’s recent newsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Can Alaunos Therapeutics Inc. recover in the next quarterOil Prices & Weekly Watchlist for Consistent Profits - newser.com
How analysts rate Alaunos Therapeutics Inc. stock todayJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
What risks investors should watch in Alaunos Therapeutics Inc. stockEarnings Summary Report & Detailed Earnings Play Alerts - newser.com
What to do if you’re stuck in Alaunos Therapeutics Inc.Quarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
How hedge fund analytics apply to Alaunos Therapeutics Inc. stock2025 Analyst Calls & Weekly High Return Forecasts - newser.com
News impact scoring models applied to Alaunos Therapeutics Inc.July 2025 Institutional & Intraday High Probability Alerts - newser.com
Risk adjusted return profile for Alaunos Therapeutics Inc. analyzedEarnings Overview Summary & Capital Protection Trade Alerts - newser.com
Order flow analysis tools used on Alaunos Therapeutics Inc.July 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-30 23:23:03 - newser.com
How Alaunos Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Patterns & AI Powered Trade Plan Recommendations - fcp.pa.gov.br
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):